In recent years, more and more effort has been invested in the identification of biomarkers
for the treatment of neuropathic pain. Given the fact that many clinical trials on development …

Patients with the same neuropathic pain disorder may have completely different sensory
signs and symptoms yet receive the same medicinal treatment. New concepts suggest that …

Background The treatment of neuropathic pain remains a major unmet need that the
development of personalized and refined treatment strategies may contribute to address …

Currently available treatments for neuropathic pain fail in roughly half of the patients–and it
is impossible to predict which treatments will help patients. Stratification of neuropathic pain …

The discussed trials show the importance of the development of an individualized pain
therapy. Up to now, no clinical trial has prospectively used the sensory phenotype as an …

Classification of neuropathic pain has been based on disease entities, anatomical
localization, or histological observations. Over the past decade, there has been an explosion …

Patients with the same disease may suffer from completely different pain symptoms yet
receive the same drug treatment. Several studies elucidate neuropathic pain and treatment …

Neuropathic pain is a common chronic pain condition that is caused by a lesion or disease
of the somatosensory nervous system. The multitude of sensory negative and positive …

Unlike the plethora of drugs available to treat epilepsy, depression, or migraine,
comparatively few and insufficiently effective drugs are available for neuropathic pain …

Neuropathic pain syndromes, ie, pain after a lesion or disease of the peripheral or central
nervous system, are clinically characterized by spontaneous pain (ongoing, paroxysms) and …